Home The Word Brain My Amedeo FAQ Privacy About   


C49

In our changing world, speaking just English isn't enough. Open new doors with skills in another world language.

Start with 7 words a day.

Next week: +49.


  Influenza

  Free Subscription


Articles published in J Gen Virol

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    May 2025
  1. AHMED MN, Abu Habib US, Abdallah AM, Emara MM, et al
    The impact of pre-existing immunity on the emergence of within-host immune-escape mutations in Omicron lineages.
    J Gen Virol. 2025;106:002108.
    PubMed     Abstract available


    April 2025
  2. SANCHEZ-MARTINEZ A, Moore T, Freitas TS, Benzaken TR, et al
    Recent advances in the prevention and treatment of respiratory syncytial virus disease.
    J Gen Virol. 2025;106.
    PubMed     Abstract available


  3. ARANDA AJ, Aguilar-Tipacamu G, Perez DR, Banuelos-Hernandez B, et al
    Emergence, migration and spreading of the high pathogenicity avian influenza virus H5NX of the Gs/Gd lineage into America.
    J Gen Virol. 2025;106:002081.
    PubMed     Abstract available


    March 2025
  4. HANKINSON J, Young D, Wignall-Fleming EB, Lukoszek R, et al
    The Cap-proximal secondary structures of the 5'UTRs of parainfluenza virus 5 mRNAs specify differential sensitivity to type I interferon and IFIT1.
    J Gen Virol. 2025;106.
    PubMed     Abstract available


    February 2025
  5. WEBB I, Erdmann M, Milligan R, Savage M, et al
    Examining the feasibility of replacing ORF3a with fluorescent genes to construct SARS-CoV-2 reporter viruses.
    J Gen Virol. 2025;106:002072.
    PubMed     Abstract available


    January 2025
  6. RANDALL RE, Young D, Pisliakova M, Andrejeva J, et al
    Single-cycle parainfluenza virus type 5 vectors for producing recombinant proteins, including a humanized anti-V5 tag antibody.
    J Gen Virol. 2025;106.
    PubMed     Abstract available


    December 2024
  7. KRISHNA B, Metaxaki M, Perera M, Wills M, et al
    Comparison of different T cell assays for the retrospective determination of SARS-CoV-2 infection.
    J Gen Virol. 2024;105.
    PubMed     Abstract available


  8. ALNAJJAR S, Larios-Mora A, Van-Geelen A, Gallup J, et al
    Therapeutic efficacy of JNJ-49214698, an RSV fusion inhibitor, in RSV-infected neonatal lambs.
    J Gen Virol. 2024;105:002056.
    PubMed     Abstract available


    November 2024
  9. BOE CA, Fiskebeck EMLZ, Reiten MR, Akerstedt J, et al
    Emergence of highly pathogenic avian influenza viruses H5N1 and H5N5 in white-tailed eagles, 2021-2023.
    J Gen Virol. 2024;105:002035.
    PubMed     Abstract available


    October 2024
  10. SAENKHAM-HUNTSINGER P, Drelich AK, Huang P, Peng BH, et al
    BALB/c mice challenged with SARS-CoV-2 B.1.351 beta variant cause pathophysiological and neurological changes within the lungs and brains.
    J Gen Virol. 2024;105:002039.
    PubMed     Abstract available


    September 2024
  11. SHIPLEY R, Seekings AH, Byrne AMP, Shukla S, et al
    SARS-CoV-2 infection and transmission via the skin to oro-nasal route with the production of bioaerosols in the ferret model.
    J Gen Virol. 2024;105:002022.
    PubMed     Abstract available


    July 2024
  12. HAVERTY R, McCormack J, Evans C, Purves K, et al
    SARS-CoV-2 infects neurons, astrocytes, choroid plexus epithelial cells and pericytes of the human central nervous system in vitro.
    J Gen Virol. 2024;105.
    PubMed     Abstract available


  13. JAMES J, Thomas SS, Seekings AH, Mahmood S, et al
    Evaluating the epizootic and zoonotic threat of an H7N9 low-pathogenicity avian influenza virus (LPAIV) variant associated with enhanced pathogenicity in turkeys.
    J Gen Virol. 2024;105.
    PubMed     Abstract available


  14. KING J, Pohlmann A, Bange A, Horn E, et al
    Red knots in Europe: a dead end host species or a new niche for highly pathogenic avian influenza?
    J Gen Virol. 2024;105.
    PubMed     Abstract available


    June 2024
  15. BORDES L, Gerhards NM, Peters S, van Oort S, et al
    H5N1 clade 2.3.4.4b avian influenza viruses replicate in differentiated bovine airway epithelial cells cultured at air-liquid interface.
    J Gen Virol. 2024;105.
    PubMed     Abstract available


    May 2024
  16. AHRENS AK, Jonsson SR, Svansson V, Brugger B, et al
    Iceland: an underestimated hub for the spread of high-pathogenicity avian influenza viruses in the North Atlantic.
    J Gen Virol. 2024;105.
    PubMed     Abstract available


  17. KARA Y, Kizil MC, Iseri Nepesov M, Kacmaz E, et al
    Assessing the change in the epidemiology of seasonal respiratory viruses with the onset of the COVID-19 pandemic.
    J Gen Virol. 2024;105.
    PubMed     Abstract available


    February 2024
  18. HARDISTY G, Nicol MQ, Shaw DJ, Bennet ID, et al
    Latent gammaherpesvirus infection enhances type I IFN response and reduces virus spread in an influenza A virus co-infection model.
    J Gen Virol. 2024;105.
    PubMed     Abstract available


    January 2024
  19. HAYES RS, Oraby AK, Camargo C, Marchant DJ, et al
    Mapping respiratory syncytial virus fusion protein interactions with the receptor IGF1R and the impact of alanine-scanning mutagenesis on viral infection.
    J Gen Virol. 2024;105.
    PubMed     Abstract available


  20. SEEKINGS AH, Liang Y, Warren CJ, Hjulsager CK, et al
    Transmission dynamics and pathogenesis differ between pheasants and partridges infected with clade 2.3.4.4b H5N8 and H5N1 high-pathogenicity avian influenza viruses.
    J Gen Virol. 2024;105.
    PubMed     Abstract available


  21. MCMILLAN CLD, Wijesundara DK, Choo JJY, Amarilla AA, et al
    Enhancement of cellular immunity following needle-free vaccination of mice with SARS-CoV-2 spike protein.
    J Gen Virol. 2024;105.
    PubMed     Abstract available


    December 2023
  22. APAA T, Withers AJ, Mackenzie L, Staley C, et al
    Lack of detection of SARS-CoV-2 in British wildlife 2020-21 and first description of a stoat (Mustela erminea) Minacovirus.
    J Gen Virol. 2023;104.
    PubMed     Abstract available


    November 2023
  23. RANDALL RE, Young DF, Hughes DJ, Goodbourn S, et al
    Persistent paramyxovirus infections: in co-infections the parainfluenza virus type 5 persistent phenotype is dominant over the lytic phenotype.
    J Gen Virol. 2023;104.
    PubMed     Abstract available


  24. GRAND RJ
    SARS-CoV-2 and the DNA damage response.
    J Gen Virol. 2023;104.
    PubMed     Abstract available


    October 2023
  25. PHILIP AA, Hu S, Dai J, Patton JT, et al
    Recombinant rotavirus expressing the glycosylated S1 protein of SARS-CoV-2.
    J Gen Virol. 2023;104.
    PubMed     Abstract available


  26. UCHECHUKWU CF, Anyaduba UL, Udekwu CC, Orababa OQ, et al
    Desmoglein-2 and COVID-19 complications: insights into its role as a biomarker, pathogenesis and clinical implications.
    J Gen Virol. 2023;104.
    PubMed     Abstract available


  27. JUCKEL D, Desmarets L, Danneels A, Rouille Y, et al
    MERS-CoV and SARS-CoV-2 membrane proteins are modified with polylactosamine chains.
    J Gen Virol. 2023;104.
    PubMed     Abstract available


    July 2023
  28. THURSZ M, Sadiq F, Tree JA, Karayiannis P, et al
    Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2.
    J Gen Virol. 2023;104.
    PubMed     Abstract available


    June 2023
  29. OKUYA K, Khalil AM, Esaki M, Nishi N, et al
    Newly emerged genotypes of highly pathogenic H5N8 avian influenza viruses in Kagoshima prefecture, Japan during winter 2020/21.
    J Gen Virol. 2023;104.
    PubMed     Abstract available


  30. MIRABELLI C, Bragazzi Cunha J, Wotring JW, Sherman EJ, et al
    ARF6 is a host factor for SARS-CoV-2 infection in vitro.
    J Gen Virol. 2023;104.
    PubMed     Abstract available


  31. APAA T, Withers AJ, Staley C, Blanchard A, et al
    Sarbecoviruses of British horseshoe bats; sequence variation and epidemiology.
    J Gen Virol. 2023;104.
    PubMed     Abstract available


    May 2023
  32. JAMES J, Billington E, Warren CJ, De Sliva D, et al
    Clade 2.3.4.4b H5N1 high pathogenicity avian influenza virus (HPAIV) from the 2021/22 epizootic is highly duck adapted and poorly adapted to chickens.
    J Gen Virol. 2023;104.
    PubMed     Abstract available


  33. DE BUHR H, de Leeuw OS, Harders F, Peeters BP, et al
    Emergence of biased hypermutation in a heterologous additional transcription unit in recombinant lentogenic Newcastle disease virus.
    J Gen Virol. 2023;104.
    PubMed     Abstract available


  34. SULLIVAN DJ, Franchini M, Senefeld JW, Joyner MJ, et al
    Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1.
    J Gen Virol. 2023;104.
    PubMed     Abstract available


    April 2023
  35. SKOG E, Nykvist M, Naguib MM, Wille M, et al
    An oseltamivir-resistant avian H1N1 influenza A virus can transmit from mallards to chickens similarly to a wild-type strain: implications for the risk of resistance transmission to humans.
    J Gen Virol. 2023;104.
    PubMed     Abstract available


  36. WOO PCY, de Groot RJ, Haagmans B, Lau SKP, et al
    ICTV Virus Taxonomy Profile: Coronaviridae 2023.
    J Gen Virol. 2023;104.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.